Untapped Potential: Opportunities and Obstacles for Pharmaceutical Logistics - Part III
Manu Raghavan

Untapped Potential: Opportunities and Obstacles for Pharmaceutical Logistics - Part III

Pharma Logistics Tomorrow: How Your Business Can CapitalizeIn the previous two issues of our in depth series on pharmaceutical logistics, we've been exploring the rapidly growing and increasingly important issue of pharmaceutical logistics. In Part I of this series, we talked about the need for time-critical air transportation that has been created by increased globalization and the steady growth of the health care sector. In Part II, we revealed that there are some considerable data and infrastructure challenges that must be first be surmounted before the air cargo industry can confidently tr...
Read More
Cold Chain Challenges: Opportunities and Obstacles for Pharmaceutical Logistics, Part II
Manu Raghavan

Cold Chain Challenges: Opportunities and Obstacles for Pharmaceutical Logistics, Part II

Pharma Logistics: Facing the ChallengesIn the previous part of our series on Pharmaceutical Logistics, we revealed the growing demand for rapid and time critical transportation of key drugs in today's interconnected world. As the pharmaceutical industry continues to see consistent growth, air freight cargo operators have a great opportunity to leverage their competitive advantage to fill this need. In this article, we'll show you some of the unique challenges presented by pharmaceutical logistics, and then show you how advanced cargo management software can address many of these issues. ...
Read More
Precious Cargo: Opportunities & Obstacles for Pharmaceutical Logistics
Manu Raghavan

Precious Cargo: Opportunities & Obstacles for Pharmaceutical Logistics

Pharma Logistics Today: A Brief OverviewIn 2013, a top pharmaceutical retailer in the US decided to donate 375,000 doses of flu vaccine to the Laos People's Democratic Republic in light of a particularly serious flu season in the region. The safe transportation of the vaccines from a US production facility to consumption in Laos presented several challenges, most important among them ensuring the integrity of the vaccine. This vaccine was travelling over 9,000 miles crossing 5 different countries, handled by multiple parties – production, packing, trucking, airline, forwarder, airport, seaport...
Read More